Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Efficacy of a therapeutic exercise program on autonomic nervous system function, cardiac function and functional capacity in colorectal cancer survivors: a randomized controlled pilot study.

Ruiz-Vozmediano J, Gutiérrez-Martínez À, Postigo-Martin P, Cruz-Fernández M, González-Flores E, Cantarero-Villanueva I.

Ann Oncol. 2019 Jul;30 Suppl 4:iv77. doi: 10.1093/annonc/mdz155.280. Epub 2019 Dec 4. No abstract available.

PMID:
32085289
2.

Clinical significance of BRAF mutations in colorectal cancer: A retrospective study of one institution in a real-life population.

Carnerero Córdoba L, González Cebrián I, Rodríguez González C, González-Flores E, Conde V, Delgado Ureña M, Jurado García J, González-Astorga B.

Ann Oncol. 2019 Jul;30 Suppl 4:iv106. doi: 10.1093/annonc/mdz155.388. Epub 2019 Dec 4. No abstract available.

PMID:
32084954
3.

Convolutional decoding of thermographic images to locate and quantify honey adulterations.

Izquierdo M, Lastra-Mejías M, González-Flores E, Cancilla JC, Pérez M, Torrecilla JS.

Talanta. 2020 Mar 1;209:120500. doi: 10.1016/j.talanta.2019.120500. Epub 2019 Oct 24.

PMID:
31892029
4.

Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer.

Martín-Blázquez A, Díaz C, González-Flores E, Franco-Rivas D, Jiménez-Luna C, Melguizo C, Prados J, Genilloud O, Vicente F, Caba O, Pérez Del Palacio J.

Sci Rep. 2019 Dec 27;9(1):20198. doi: 10.1038/s41598-019-55952-8.

5.

Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM.

Vera R, González-Flores E, Rubio C, Urbano J, Valero Camps M, Ciampi-Dopazo JJ, Orcajo Rincón J, Morillo Macías V, Gomez Braco MA, Suarez-Artacho G.

Clin Transl Oncol. 2020 May;22(5):647-662. doi: 10.1007/s12094-019-02182-z. Epub 2019 Jul 29.

PMID:
31359336
6.

Correction to: Recommendations for follow‑up of colorectal cancer survivors.

Vera R, Aparicio J, Carballo F, Esteva M, González-Flores E, Santianes J, Santolaya F, Fernández-Cebrián JM.

Clin Transl Oncol. 2019 Oct;21(10):1440. doi: 10.1007/s12094-019-02088-w.

PMID:
30924092
7.

Recommendations for follow-up of colorectal cancer survivors.

Vera R, Aparicio J, Carballo F, Esteva M, González-Flores E, Santianes J, Santolaya F, Fernández-Cebrián JM.

Clin Transl Oncol. 2019 Oct;21(10):1302-1311. doi: 10.1007/s12094-019-02059-1. Epub 2019 Feb 14. Erratum in: Clin Transl Oncol. 2019 Mar 28;:.

PMID:
30762206
8.

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018).

Gómez-España MA, Gallego J, González-Flores E, Maurel J, Páez D, Sastre J, Aparicio J, Benavides M, Feliu J, Vera R.

Clin Transl Oncol. 2019 Jan;21(1):46-54. doi: 10.1007/s12094-018-02002-w. Epub 2018 Dec 18.

9.

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018).

González-Flores E, Serrano R, Sevilla I, Viúdez A, Barriuso J, Benavent M, Capdevila J, Jimenez-Fonseca P, López C, Garcia-Carbonero R.

Clin Transl Oncol. 2019 Jan;21(1):55-63. doi: 10.1007/s12094-018-1980-7. Epub 2018 Dec 7.

10.

[The most frequent causative agents of Guillain-Barre syndrome in a Mexican general hospital].

Del Carpio-Orantes L, Pola-Ramirez MR, Garcia-Mendez S, Mata-Miranda MP, Perfecto-Arroyo MA, Solis-Sanchez I, Trujillo-Ortega BM, Gonzalez-Flores EE.

Rev Neurol. 2018 Sep 16;67(6):203-209. Spanish.

11.

Guillain-Barré syndrome associated with Zika virus infection: Analysis of a cohort from the region of northern Veracruz in 2016-2017.

Del Carpio-Orantes L, Peniche Moguel KG, Sánchez Díaz JS, Pola-Ramirez MDR, Mata Miranda MDP, García-Méndez S, Perfecto-Arroyo MA, Solís-Sánchez I, Trujillo-Ortega BM, González-Flores EE.

Neurologia. 2018 Jul 30. pii: S0213-4853(18)30173-7. doi: 10.1016/j.nrl.2018.05.002. [Epub ahead of print] English, Spanish. No abstract available.

12.

The Medical Oncology resident mentor: situation and workload.

Elez E, Quintanar T, Bosch-Barrera J, Corral J, Lainez N, Moreno V, Rodriguez CA, Gonzalez-Flores E, Cervantes A.

Clin Transl Oncol. 2019 Mar;21(3):304-313. doi: 10.1007/s12094-018-1923-3. Epub 2018 Jul 30.

PMID:
30062521
13.

First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.

Aranda E, García-Alfonso P, Benavides M, Sánchez Ruiz A, Guillén-Ponce C, Safont MJ, Alcaide J, Gómez A, López R, Manzano JL, Méndez Ureña M, Sastre J, Rivera F, Grávalos C, García T, Martín-Valadés JI, Falcó E, Navalón M, González Flores E, Ma García Tapiador A, Ma López Muñoz A, Barrajón E, Reboredo M, García Teijido P, Viudez A, Cárdenas N, Díaz-Rubio E; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).

Eur J Cancer. 2018 Sep;101:263-272. doi: 10.1016/j.ejca.2018.06.024. Epub 2018 Jul 24.

PMID:
30054049
14.

General recommendations paper on the management of older patients with cancer: the SEOM geriatric oncology task force's position statement.

Gironés Sarrió R, Antonio Rebollo M, Molina Garrido MJ, Guillén-Ponce C, Blanco R, Gonzalez Flores E, Saldaña J; Spanish Working Group on Geriatric Oncology of the Spanish Society of Medical Oncology (SEOM).

Clin Transl Oncol. 2018 Oct;20(10):1246-1251. doi: 10.1007/s12094-018-1856-x. Epub 2018 Apr 9.

15.

Case Report: Propranolol increases the therapeutic response to temozolomide in a patient with metastatic paraganglioma.

Díaz-Castellanos MA, Gómez de Las Heras KV, Díaz-Redondo T, González-Flores E, Albiñana V, Botella LM.

F1000Res. 2017 Dec 4;6:2087. doi: 10.12688/f1000research.13185.1. eCollection 2017.

16.

Geriatric oncology in Spain: survey results and analysis of the current situation.

Gironés R, Morilla I, Guillen-Ponce C, Torregrosa MD, Paredero I, Bustamante E, Del Barco S, Soler G, Losada B, Visa L, Llabrés E, Fox B, Firvida JL, Blanco R, Antonio M, Aparisi F, Pi-Figueras M, Gonzalez-Flores E, Molina-Garrido MJ, Saldaña J; Spanish Working Group on Geriatric Oncology of the Spanish Society of Medical Oncology (SEOM).

Clin Transl Oncol. 2018 Aug;20(8):1087-1092. doi: 10.1007/s12094-017-1813-0. Epub 2017 Dec 11.

17.

Analysis retrospective from efficacy with TAS-102 in patients with metastatic colorectal cancer refractory: Experience at two hospitals.

González-Astorga B, González Cebrián I, Delgado Ureña Ma T, Conde V, Sánchez-Toro C, García-García J, González-Flores E.

Ann Oncol. 2017 Jun;28 Suppl 3:iii117. doi: 10.1093/annonc/mdx261.328. No abstract available.

18.

Experience with aflibercept as a second line chemotherapy in metastatic colorectal cancer: Safety and efficacy in a real-life population.

González-Flores E, González-Astorga B, Delgado Ureña Ma T, González Cebrián I, Sánchez-Toro C, García-García J, Conde V.

Ann Oncol. 2017 Jun;28 Suppl 3:iii110-iii111. doi: 10.1093/annonc/mdx261.314. No abstract available.

19.

SEOM Clinical Guideline of localized rectal cancer (2016).

González-Flores E, Losa F, Pericay C, Polo E, Roselló S, Safont MJ, Vera R, Aparicio J, Cano MT, Fernández-Martos C.

Clin Transl Oncol. 2016 Dec;18(12):1163-1171. doi: 10.1007/s12094-016-1591-0. Epub 2016 Nov 30.

20.

New clinical trials regulation in Spain: analysis of royal decree 1090/2015.

Martin Jimenez M, Calvo Ferrandiz A, Aparicio Urtasun J, Garcia-Campelo R, Gonzalez-Flores E, Lazaro Quintela M, Muñoz Mateu M, Rodriguez Sanchez CA, Santaballa Bertran A, Sepulveda Sanchez JM, Vera Garcia R, Virizuela Echaburu JA, Segui Palmer MA.

Clin Transl Oncol. 2017 Mar;19(3):291-300. doi: 10.1007/s12094-016-1550-9. Epub 2016 Oct 7.

21.

SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.

García-Carbonero R, Vera R, Rivera F, Parlorio E, Pagés M, González-Flores E, Fernández-Martos C, Corral MÁ, Bouzas R, Matute F.

Clin Transl Oncol. 2017 Feb;19(2):135-148. doi: 10.1007/s12094-016-1518-9. Epub 2016 May 20.

PMID:
27206566
22.

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study.

Garcia-Alfonso P, Chaves M, Muñoz A, Salud A, García-Gonzalez M, Grávalos C, Massuti B, González-Flores E, Queralt B, López-Ladrón A, Losa F, Gómez MJ, Oltra A, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD).

BMC Cancer. 2015 Apr 29;15:327. doi: 10.1186/s12885-015-1293-y.

23.

SEOM clinical guidelines for the adjuvant treatment of colorectal cancer 2013.

Maurel J, Grávalos C, Rivera F, Vera R, González Flores E; SEOM.

Clin Transl Oncol. 2013 Dec;15(12):991-5. doi: 10.1007/s12094-013-1083-4. Epub 2013 Sep 13. Review.

PMID:
24026866
24.

Pilot study on workload estimate in breast cancer, lung cancer and colorectal cancer in a Medical Oncology Service at Valme hospital.

Salvador J, Grávalos C, Albanell J, Barnadas A, Borrega P, García-Mata J, Garrido P, Gonzalez-Flores E, Isla D, Lomas M, Rodríguez-Lescure A, Cruz JJ, Alba E.

Clin Transl Oncol. 2012 Nov;14(11):820-6. doi: 10.1007/s12094-012-0873-4. Epub 2012 Aug 2.

PMID:
22855162
25.

Functions and workload of medical oncologists in Spain.

Grávalos C, Salvador J, Albanell J, Barnadas A, Borrega P, García-Mata J, Garrido P, González-Flores E, Isla D, Lomas M, Rodríguez-Lescure Á, Cruz JJ, Alba E; Spanish Society for Medical Oncology (SEOM).

Clin Transl Oncol. 2012 Jun;14(6):423-9. Review.

PMID:
22634530
26.

Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.

Benavides M, Pericay C, Valladares-Ayerbes M, Gil-Calle S, Massutí B, Aparicio J, Dueñas R, González-Flores E, Carrato A, Marcuello E, Gómez A, Cabrera E, Queralt B, Gómez MJ, Guasch I, Etxeberría A, Alfaro J, Campos JM, Reina JJ, Aranda E.

Clin Colorectal Cancer. 2012 Sep;11(3):200-6. doi: 10.1016/j.clcc.2012.01.003. Epub 2012 Mar 14.

PMID:
22421001
27.

Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain.

Vieitez JM, García-Carbonero R, Aparicio J, Feliu J, González-Flores E, Grande E, Pérez-Hoyos T, Salud A, Torres E, Valero M, Valladares-Ayerbes M, Díaz-Rubio E.

Clin Transl Oncol. 2011 Nov;13(11):798-804. doi: 10.1007/s12094-011-0736-4.

PMID:
22082644
28.

[Assessment of comorbidity in elderly].

Rosas-Carrasco O, González-Flores E, Brito-Carrera AM, Vázquez-Valdez OE, Peschard-Sáenz E, Gutiérrez-Robledo LM, García-Mayo EJ.

Rev Med Inst Mex Seguro Soc. 2011 Mar-Apr;49(2):153-62. Review. Spanish.

PMID:
21703142
29.

SEOM clinical guidelines for the treatment of advanced colorectal cancer.

García-Carbonero R, Gómez España MA, Casado Sáenz E, Alonso Orduña V, Cervantes Ruipérez A, Gallego Plazas J, García Alfonso P, Juez Martel I, González Flores E, Lomas Garrido M, Isla Casado D; SEOM (Spanish Society for Medical Oncology).

Clin Transl Oncol. 2010 Nov;12(11):729-34.

PMID:
20974564
30.

SEOM clinical guidelines for the adjuvant treatment of colorectal cancer.

Grávalos Castro C, Maurel Santasusana J, Rivera Herrero F, Salazar Soler R, Sevilla García I, Sastre Valera J, Tabernero Caturla JM, González Flores E, Lomas Garrido M, Isla Casado D; SEOM (spanish Society for Medical Oncology).

Clin Transl Oncol. 2010 Nov;12(11):724-8.

PMID:
20974563
31.

Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group.

Garcia-Alfonso P, Muñoz-Martin A, Mendez-Ureña M, Quiben-Pereira R, Gonzalez-Flores E, Perez-Manga G.

Br J Cancer. 2009 Oct 6;101(7):1039-43. doi: 10.1038/sj.bjc.6605261. Epub 2009 Sep 8.

32.

Biochemotherapy in the treatment of metastatic melanoma in selected patients.

González Astorga B, Jiménez Rubiano B, Delgado Pérez JR, Valdivia Bautista J, Sánchez Toro C, González Flores E, Luque Caro R, Castellón Rubio V.

Clin Transl Oncol. 2009 Jun;11(6):382-6. Review.

PMID:
19531453
33.

Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study.

Sastre J, Aranda E, Massutí B, Tabernero J, Chaves M, Abad A, Carrato A, Reina JJ, Queralt B, Gómez-España A, González-Flores E, Rivera F, Losa F, García T, Sanchez-Rovira P, Maestu I, Díaz-Rubio E.

Crit Rev Oncol Hematol. 2009 May;70(2):134-44. doi: 10.1016/j.critrevonc.2008.11.002. Epub 2008 Dec 25.

PMID:
19111473
34.

A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer.

Bayo-Calero JL, Mayordomo JI, Sánchez-Rovira P, Pérez-Carrión R, Illaramendi JJ, García-Bueno JM, González-Flores E, Crespo C, Ramos-Vázquez M, García-Palomo A, Ruiz-Borrego M, de la Haba J, Gómez-Bernal A, Yubero-Esteban A.

Clin Breast Cancer. 2008 Jun;8(3):264-8. doi: 10.3816/CBC.2008.n.030.

PMID:
18650157
35.

Strong association of chromosome 1p12 loci with thyroid cancer susceptibility.

Baida A, Akdi M, González-Flores E, Galofré P, Marcos R, Velázquez A.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1499-504. doi: 10.1158/1055-9965.EPI-07-0235.

36.

Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.

Díaz-Rubio E, Tabernero J, Gómez-España A, Massutí B, Sastre J, Chaves M, Abad A, Carrato A, Queralt B, Reina JJ, Maurel J, González-Flores E, Aparicio J, Rivera F, Losa F, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.

J Clin Oncol. 2007 Sep 20;25(27):4224-30. Epub 2007 Jun 4.

PMID:
17548839
37.

Medication errors.

González-Flores EA.

Am Pharm. 1993 Jul;NS33(7):4. No abstract available.

PMID:
8342495
38.

Reactions of phosphoproteins in alkaline solutions.

Sen LC, Gonzalez-Flores E, Feeney RE, Whitaker JR.

J Agric Food Chem. 1977 May-Jun;25(3):632-8. No abstract available.

PMID:
16046

Supplemental Content

Loading ...
Support Center